Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer
cells, either by killing the cells or by stopping them from dividing. Giving drugs in
different combinations may kill more cancer cells. It is not yet know which treatment regimen
is more effective in treating Hodgkin lymphoma.
PURPOSE: This phase III trial is studying three different therapy regimens to compare how
well they work in treating patients with previously untreated Hodgkin lymphoma.